According to a recent LinkedIn post from Xeltis, the company plans to participate in the Dialysezugangs Symposium in Hamburg, Germany, on April 18, with a booth presence throughout the event. The post notes that Dr. Alexander Meyer is scheduled to present the firm’s in situ vascular tissue engineering approach to dialysis access, highlighting a resorbable shunt prosthesis concept in a morning session.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post also indicates that Principal Medical Scientific Lead Hannah Bauer will attend and that visitors can learn more about the aXess hemodialysis conduit at the booth or via arranged meetings. For investors, this visibility at a specialized vascular access conference may support clinician awareness, early adoption, and validation of Xeltis’ dialysis access technology, potentially strengthening its positioning in the hemodialysis access market over the medium term.